AMA
Terepka A, Pryczynicz A, Reszeć-Giełażyn J. Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience. Medical Studies/Studia Medyczne. 2026. doi:10.5114/ms.2026.162418.
APA
Terepka, A., Pryczynicz, A., & Reszeć-Giełażyn, J. (2026). Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience. Medical Studies/Studia Medyczne. https://doi.org/10.5114/ms.2026.162418
Chicago
Terepka, Anna, Anna Pryczynicz, and Joanna Reszeć-Giełażyn. 2026. "Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience". Medical Studies/Studia Medyczne. doi:10.5114/ms.2026.162418.
Harvard
Terepka, A., Pryczynicz, A., and Reszeć-Giełażyn, J. (2026). Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience. Medical Studies/Studia Medyczne. https://doi.org/10.5114/ms.2026.162418
MLA
Terepka, Anna et al. "Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience." Medical Studies/Studia Medyczne, 2026. doi:10.5114/ms.2026.162418.
Vancouver
Terepka A, Pryczynicz A, Reszeć-Giełażyn J. Analysis of cervical cancer screening attendance before, during, and after the COVID-19 pandemic: six-year laboratory experience. Medical Studies/Studia Medyczne. 2026. doi:10.5114/ms.2026.162418.
